Quoted Micro 20 October 2025

AQUIS STOCK EXCHANGE ProBiotix Health (PBX) increased sales 30% to £1.97m in the nine months to September 2025. There is sufficient cash for the company’s needs. A commercial partnership with RevivaBio has been set up to launch a new cholesterol lowering product powered by the ProBiotix patented probiotic strain LPLDL®. Chairman Adam Rynolds bought 100,000 […]

Quoted Micro 8 September 2025

AQUIS STOCK EXCHANGE AI technology developer Astrid Intelligence (ASTR) moved from the Main Market to the Access segment of Aquis on 3 September. The company was previously a CBD and health products retailer known as Cellular Goods and most recently it was called Cel AI. It is developing autonomous AI agents that provide personalised wellness […]

Quoted Micro 17 March 2025

AQUIS STOCK EXCHANGE All Things Considered (ATC) has raised its stake in Brighton venture Concorde 2 to 80% and acquired the remaining shares in bar services provider JTR Productions for £2.49m and 60% of Brighton venue Volks, which is close to Concorde 2, for £400,000. This broadens the range of music-related services that can be […]

Quoted Micro 11 July

ISDX Positive Healthcare (DOC) has made its initial acquisitions since floating its 7% secured bonds on the ISDX Growth Market. Positive bought 75%  of each of two healthcare recruitment businesses, Capital Care and Fine Locums, for a total of £1.57m.  Positive Healthcare chairman Gary Ashworth has loaned the company £570,000 to help fund the acquisitions. The two […]